ENTITY
CANbridge Pharmaceuticals

CANbridge Pharmaceuticals (1228 HK)

7
Analysis
Health CareChina
CANbridge Pharmaceuticals operates as a global biopharmaceutical company. The Company focuses on developing and commercialising therapeutics for treatment of orphan diseases and rare cancers. CANbridge Pharmaceuticals serves customers worldwide.
more
Company Presentation05 Sep 2023 00:00
Company Presentation26 Aug 2022 00:00
Company Presentation01 Apr 2023 00:00
Company Presentation01 Sep 2023 00:00
No more presentations
x